Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.
about
Identification of a heparin-binding region of rat thyroglobulin involved in megalin binding.Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanismRole of thyroglobulin endocytic pathways in the control of thyroid hormone release.Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells.Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.Protein-induced supramolecular disassembly of amphiphilic polypeptide nanoassemblies.Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy.Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.FGF2-Heparin co-crystal complex-assisted design of mutants FGF1 and FGF7 with predictable heparin affinities.Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor.
P2860
Q30791305-C2D4EB7A-B6B5-4EF8-A3B8-98914BB63D44Q33805943-311A3FFA-C6B8-43D6-8E8B-4F63D1E5E982Q34058665-BF0EF325-3CF7-4B44-A83B-9850A5FEA3A2Q36166776-8EB4E0B2-82E8-4B79-87C0-1FD683C3D5B5Q36247964-28F0554C-472C-4FCC-9902-A77E7D285514Q36639272-6A96E30C-DA32-40BD-9673-28C9F3981398Q37028284-3F46500B-6DCE-4EBD-B818-B7A863244A73Q37175328-1B7F835E-C529-4BB4-9890-22AE2E700778Q38294916-DF972447-B67D-4B17-8587-86845D22A410Q38528036-2ABB1CF3-E905-447C-BB76-451765E38E7AQ41026342-4D8E6FBE-B286-4345-8650-C18D5C060C31Q42550713-6A86117F-FE12-4432-8E38-B4E4AE608F7AQ42576867-C9365D7B-B730-4749-B295-75E0CBD3693EQ54967453-2DE85F82-81F4-4DD2-B6AB-4BC2C6CBFA0F
P2860
Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Analysis of putative heparin-b ...... genesis and peptide analogues.
@en
Analysis of putative heparin-b ...... genesis and peptide analogues.
@nl
type
label
Analysis of putative heparin-b ...... genesis and peptide analogues.
@en
Analysis of putative heparin-b ...... genesis and peptide analogues.
@nl
prefLabel
Analysis of putative heparin-b ...... genesis and peptide analogues.
@en
Analysis of putative heparin-b ...... genesis and peptide analogues.
@nl
P2093
P356
P1476
Analysis of putative heparin-b ...... agenesis and peptide analogues
@en
P2093
P304
25805-25811
P356
10.1074/JBC.270.43.25805
P407
P577
1995-10-01T00:00:00Z